Generic Meridia 15 mg

Meridia 15 mg medication or Sibutramine was withdrawn from the United States (US) market because of serious cardiovascular events and risks. Meridia 15 mg medication was used for treating patients suffering from obesity. In order to manage obesity that may be associated with diabetes, high cholesterol, or high blood pressure, this medication was used in conjunction with diet and exercise. This drug was the branded medication for the generic medicine known by the name Sibutramine hydrochloride or Sibutramine Hydrochloride Monohydrate.

Meridia 15 mg drug aids in weight loss and obesity by altering the neurotransmitters of the brain and was used along with a low-calorie diet to help patients with obesity lose weight. Along with treating obesity, this medication was also known as appetite suppressant. According to several trials, it was found that this medication was effective for individuals who want to suppress their appetite. After taking the optimal dosage of 10 mg of this drug people were able to experience a decrease in their hunger and craving.

Desmethylsibutramine (metabolite 1 or M1) and Didesmethylsibutramine (metabolite 2 or M2) were the active metabolites of Meridia 15 mg. This medication was available in the form of capsules that were administered orally. The users of this medication were able to feel the efficacy of this drug within around 1 hour of being taken. Whereas, the half-life of this medicine was also 1 hour.

Meridia 15 mg was a prescription-only drug and was classified as a Controlled Substance Schedule IV medication. However, several side effects and risks were also associated with this drug such as chills, body aches, painful menstruation, increased blood pressure, skin rash, and many more.